Organization: Health Canada
Year: 2025
Month: January
Request Number: A-2021-001973
Request Summary: The Screening acceptance letter(s) sent from Health Canada to any and all generic drug manufacturer(s) for any and all Abbreviated New Drug Submission(s) (ANDS) for the medicinal ingredient risperidone which appear(s) on the list of Generic Drug Submissions under Review (GSUR).The Module 2.2 indicating the brand name of the reference drug product and the dosage form of risperidone in any and all ANDS for the medicinal ingredient risperidone which appear(s) on the list of GSUR.
Disposition: Disclosed in part
Number of pages: 2